- Home
- / Inspyr Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Inspyr Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.1
2021-11-10
Market Capitalization
$1.4 M
2021-11-10
CreditSafe Score
?
Score changed on Jun 17, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General and administrative expense | 3.3M | 4.0M | 3.7M | 3.3M | 3.8M | 2.1M | 1.7M | 516.0K | 565.0K | 494.0K | 528.0K | 425.0K |
| Operating expense total | 6.6M | 6.9M | 6.4M | 7.0M | 6.1M | 3.2M | 3.4M | 724.0K | 609.0K | 512.0K | 664.0K | |
| EBIT | (6.3M) | (6.9M) | (6.4M) | (7.0M) | (6.1M) | (3.2M) | (5.9M) | (724.0K) | (609.0K) | (2.5M) | (1.0M) | (664.0K) |
| Interest income | 26.0K | 5.0K | ||||||||||
| Interest expense | 4.0K | 2.9M | 5.2M | 550.0K | 777.0K | 302.0K | (1.1M) | 69.0K | ||||
| Pre tax profit | (5.7M) | (6.9M) | (5.3M) | (7.0M) | (5.9M) | (3.6M) | (11.1M) | (12.0K) | (934.0K) | (6.3M) | 2.7M | (1.0M) |
| Net Income | (5.7M) | (6.9M) | (5.3M) | (7.0M) | (5.9M) | (3.6M) | (11.1M) | (12.0K) | (934.0K) | (6.3M) | 2.7M | (1.0M) |
| EPS | 0.0 |